Telcare raises $32.5 million in Series C funding


Telcare — the company behind the world’s first cellular-enabled blood glucose meter, diabetes mobile app, and HIPAA-compliant cloud platform — has raised $32.5 million in a Series C round of funding, led by Norwest Venture Partners (NVP). Also participating in the round were Mosaic Health Solutions, as well as existing investors Sequoia and Qualcomm. As part of the deal, NVP Partner’s Casper de Clerq will join the Telcare board.

The Telserve Cloud Platform is the only FDA-cleared cellular BGM platform that connects everyone who can help a patient manage a condition and the devices required for timely diagnostics and condition tracking. The solution proactively delivers messages and reminders, along with personalized education, and keeps the patient’s doctor in the loop with updates and timely diagnostic data capture.

“Telcare is applying advances in consumer electronics and cloud computing to simplify life and improve diabetes care,” said Andrew Flanagan, Telcare CEO. “Empowering patients and healthcare providers leads to improved coordination and health. This investment enables us to deliver on our vision by scaling our reach and capabilities.”

Many leading health plans cover the cost of the Telserve Cloud to embrace those living with diabetes, helping them better manage chronic conditions to improve health and lower the cost of care.